I agree that this site is using cookies. You can find further informations here.
X
Boot, E.
948  results:
Search for persons X
?
1

Cannabidiol (Epidyolex®) for severe behavioral manifestatio..:

Müller, A. R. ; den Hollander, B. ; van de Ven, P. M....
BMC Psychiatry.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Methylphenidate for attention-deficit/hyperactivity disorde..:

Müller, A. R. ; Zinkstok, J. R. ; Rommelse, N. N. J....
Orphanet Journal of Rare Diseases.  16 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
3

Neurocognition and adaptive functioning in a genetic high r..:

Fiksinski, A. M. ; Breetvelt, E. J. ; Lee, Y. J....
Psychological Medicine.  49 (2018)  6 - p. 1047-1054 , 2018
Link: https://doi.org/10.1017/..
 
?
4

Cerebral dopamine deficiency, plasma monoamine alterations ..:

Boot, E. ; Hollak, C. E. M. ; Huijbregts, S. C. J....
Psychological Medicine.  47 (2017)  16 - p. 2854-2865 , 2017
Link: https://doi.org/10.1017/..
 
?
5

Distinct white-matter aberrations in 22q11.2 deletion syndr..:

Bakker, G. ; Caan, M. W. A. ; Schluter, R. S....
Psychological Medicine.  46 (2016)  11 - p. 2299-2311 , 2016
Link: https://doi.org/10.1017/..
 
?
6

OC15.03: Management of severe fetal growth restriction befo..:

Bijma, H. ; Boot, E. ; Bekker, M..
Ultrasound in Obstetrics & Gynecology.  46 (2015)  S1 - p. 32-32 , 2015
Link: https://doi.org/10.1002/..
 
?
7

P.3.b.026 Differences in cortical morphology between 22q11...:

Bakker, G. ; Caan, M.W.A. ; Vingerhoets, W.A.M....
European Neuropsychopharmacology.  25 (2015)  - p. S478 , 2015
Link: https://doi.org/10.1016/..
 
?
8

P.6.f.005 Prevalence of substance use and the relation with..:

Vingerhoets, W.A.M. ; Van Oudenaren, M.J.F. ; Van Duin, E.D.A....
European Neuropsychopharmacology.  25 (2015)  - p. S630 , 2015
Link: https://doi.org/10.1016/..
 
?
9

P.3.b.024 Changes in white matter microstructure integrity ..:

Bakker, I.M. ; Van Dijk, L. ; Caan, M.W.A....
European Neuropsychopharmacology.  25 (2015)  - p. S477-S478 , 2015
Link: https://doi.org/10.1016/..
 
?
10

OC15.02: Management of severe fetal growth restriction befo..:

Boot, E. ; Bijma, H. ; Bekker, M..
Ultrasound in Obstetrics & Gynecology.  46 (2015)  S1 - p. 31-32 , 2015
Link: https://doi.org/10.1002/..
 
?
11

P.1.i.010 Spectroscopy differences between at risk populati..:

Bloemen, O. ; Vingerhoets, W. ; Bakker, G....
European Neuropsychopharmacology.  25 (2015)  - p. S304-S305 , 2015
Link: https://doi.org/10.1016/..
 
?
12

P.1.g.079 Dopaminergic neurotransmission in clinical and ge..:

Van Amelsvoort, T. ; Bloemen, O. ; Boot, E...
European Neuropsychopharmacology.  23 (2013)  - p. S236 , 2013
Link: https://doi.org/10.1016/..
 
?
13

Striatal D2receptor binding in 22q11 deletion syndrome: an ..:

Boot, E. ; Booij, J. ; Zinkstok, JR...
Journal of Psychopharmacology.  24 (2009)  10 - p. 1525-1531 , 2009
Link: https://doi.org/10.1177/..
 
?
14

AlSiTiN nanocomposite coatings developed via Arc Cathodic P..:

Faga, M.G. ; Gautier, G. ; Calzavarini, R....
Wear.  263 (2007)  7-12 - p. 1306-1314 , 2007
Link: https://doi.org/10.1016/..
 
?
15

KARMEN-Upgrade: Status and first results:

Kleinfeller, J. ; Armbruster, B. ; Blair, I....
Nuclear Physics B - Proceedings Supplements.  66 (1998)  1-3 - p. 378-381 , 1998
Link: https://doi.org/10.1016/..
 
1-15